Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Acta Clinica Croatica|December 4, 2025
OPTIMIZATION OF HCV CELL CULTURE SYSTEM FOR EVALUATION OF ANTIVIRAL DRUGS AGAINST HCV GENOTYPES 2a AND 4aNaiera M Helmy, Reem El-Shenawy, Tawfeek H Abdelhafez, et al.
BMC Biotechnology|January 18, 2025
Development of Virus-Like Particles (VLPs) for Hepatitis C Virus genotype 4: a novel approach for vaccine development in EgyptAhmed A Ali, Rasha A M Azouz, Nahla A Hussein, et al.
IUBMB Life|September 13, 2019
MicroRNAs expression profiling in Egyptian colorectal cancer patientsNoha G Bader El Din, Marwa K Ibrahim, Reem El-Shenawy, et al.
Human Antibodies|June 26, 2014
Establishment of human clones producing neutralizing human monoclonal antibodies to the envelope E1/E2 protein of hepatitis C virus by EBV immortalization of immune CD22⁺ B cellsAshraf Tabll, Yasmine El Abd, Noha G Bader El Din, et al.
Journal of Immunoassay & Immunochemistry|March 11, 2014
Antiviral activity of virocidal peptide derived from NS5A against two different HCV genotypes: an in vitro studyReem El-Shenawy, Ashraf Tabll, Noha G Bader El Din, et al.
Viral Immunology|October 28, 2015
Impact of OAS1 Exon 7 rs10774671 Genetic Variation on Liver Fibrosis Progression in Egyptian HCV Genotype 4 PatientsNoha G Bader El Din, Mohamed A Anany, Reham M Dawood, et al.
Viral Immunology|February 3, 2017
The Synergistic Effect of TNFα -308 G/A and TGFβ1 -509 C/T Polymorphisms on Hepatic Fibrosis Progression in Hepatitis C Virus Genotype 4 PatientsNoha G Bader El Din, Sally Farouk, Reem El-Shenawy, et al.
BMC Infectious Diseases|November 7, 2019
A multiepitope peptide vaccine against HCV stimulates neutralizing humoral and persistent cellular responses in miceReham M Dawood, Rehab I Moustafa, Tawfeek H Abdelhafez, et al.
Virus Research|January 4, 2011
WITHDRAWN: Caprine antibodies towards E2 conserved peptides interfere with hepatitis C virus infectivity in vitroYasmine S Elabd, Ashraf A Tabll, Noha G Bader El Din, et al.
Human Antibodies|October 18, 2017
Neutralizing activity and safety of human monoclonal antibodies against hepatitis C virusCamelia A Abdel Malak, Tawfeek H Abelhafez, Ashraf A Tabll, et al.
Pageof 4